'It should encourage us'

A statewide task force found positive trends for childhood cancer in South Carolina, including an 11% improvement in childhood cancer survival over a 25-year period.

Read about the report
a teenage boy wearing glasses and a navy blue hoodie stands in a hospital corridor

News

New therapy for small cell lung cancer offered at Hollings

A doctor in a white coat sits to chat with a patient, who has her back facing the camera

A newly approved targeted therapy for small cell lung cancer patients whose cancer has not responded or stopped responding to chemotherapy is at the forefront of a new type of drug for solid tumors. The team at Hollings is already experienced at delivering the drug, called tarlatamab, having participated in an arm of the clinical trial.

“It will be incredible to have more drugs of this nature, which is where the oncology solid tumor field is moving,” said Mariam Alexander, M.D., Ph.D.

Read about the drug

Facebook icon Twitter icon Instagram icon LinkedIn logo icon

What’s great is now everyone can get it. Anyone can prescribe it. They don’t have to travel somewhere to get this medication. It really is a huge help for our families and kids.

Dr. Jacqueline Kraveka, pediatric cancer researcher

Read about the new drug
Jacqueline Kraveka headshot

Featured video

Dr. Evan Graboyes discusses the Survivorship and Cancer Outcomes Research (SCOR) Initiative and the impact of funding from LOWVELO, Hollings' fundraising bike ride for cancer research.

Explore the News Center

Hollings Horizons Magazine   |   Media Relations   |   Cross Talk   |   Subscribe